{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:27:19Z","timestamp":1787750839251,"version":"build-2784847793"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81960681"],"award-info":[{"award-number":["81960681"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"2024 Drug Safety Research Project","award":["ADR2024MS15"],"award-info":[{"award-number":["ADR2024MS15"]}]},{"name":"the Guizhou Provincial People\u2019s Hospital 2019 National Natural Science Foundation of China post-subsidy fund","award":["GPPH-NSFC-2019-26"],"award-info":[{"award-number":["GPPH-NSFC-2019-26"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02765-6","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:01:40Z","timestamp":1761811300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Predictive value of systemic inflammation response index for atherosclerotic cardiovascular disease risk in patients with hypercholesterolemia: a machine learning study with dual-cohort validation"],"prefix":"10.1186","volume":"24","author":[{"given":"Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoqi","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhen","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changcheng","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"issue":"3","key":"2765_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.gheart.2018.09.511","volume":"13","author":"H Thomas","year":"2018","unstructured":"Thomas H, Diamond J, Vieco A, et al. Global atlas of cardiovascular disease 2000\u20132016: the path to prevention and control. Glob Heart. 2018;13(3):143\u201363.","journal-title":"Glob Heart"},{"issue":"5","key":"2765_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.arcmed.2015.06.006","volume":"46","author":"S Barquera","year":"2015","unstructured":"Barquera S, Pedroza-Tob\u00edas A, Medina C, et al. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res. 2015;46(5):328\u201338.","journal-title":"Arch Med Res"},{"issue":"Suppl 1","key":"2765_CR3","first-page":"s3","volume":"16","author":"HH Wang","year":"2017","unstructured":"Wang HH, Garruti G, Liu M, Portincasa P, Wang DQ. Cholesterol and lipoprotein metabolism and atherosclerosis: recent advances in reverse cholesterol transport. Ann Hepatol. 2017;16(Suppl 1):s3-105.","journal-title":"Ann Hepatol"},{"issue":"10","key":"2765_CR4","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1161\/ATVBAHA.120.316389","volume":"41","author":"UK Dhawan","year":"2021","unstructured":"Dhawan UK, Bhattacharya P, Narayanan S, Manickam V, Aggarwal A, Subramanian M. Hypercholesterolemia impairs clearance of neutrophil extracellular traps and promotes inflammation and atherosclerotic plaque progression. Arterioscler Thromb Vasc Biol. 2021;41(10):2598\u2013615.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2765_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.48147","volume":"5","author":"RD Santos","year":"2022","unstructured":"Santos RD. Calcified and noncalcified coronary plaques and atherosclerotic cardiovascular events in patients with severe hypercholesterolemia-moving forward with risk stratification and therapy. JAMA Netw Open. 2022;5(2):e2148147.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2765_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/clinchem\/hvaa252","volume":"67","author":"RC Hoogeveen","year":"2021","unstructured":"Hoogeveen RC, Ballantyne CM. Residual cardiovascular risk at low LDL: remnants, lipoprotein(a), and inflammation. Clin Chem. 2021;67(1):143\u201353.","journal-title":"Clin Chem"},{"issue":"22","key":"2765_CR7","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1093\/eurheartj\/ehad241","volume":"44","author":"G Liuzzo","year":"2023","unstructured":"Liuzzo G, Patrono C. Targeting residual cardiovascular risk in the statin era: cholesterol or inflammation? Eur Heart J. 2023;44(22):1973\u20135.","journal-title":"Eur Heart J"},{"issue":"3","key":"2765_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/biom8030080","volume":"8","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Xian X, Wang Z, et al. Research progress on the relationship between atherosclerosis and inflammation. Biomolecules. 2018;8(3):80.","journal-title":"Biomolecules"},{"key":"2765_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179553","author":"EA Dziedzic","year":"2022","unstructured":"Dziedzic EA, G\u0105sior JS, Tuzimek A, et al. Investigation of the associations of novel inflammatory biomarkers-systemic inflammatory index (SII) and systemic inflammatory response index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23179553.","journal-title":"Int J Mol Sci"},{"key":"2765_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1281839","volume":"14","author":"W Dong","year":"2023","unstructured":"Dong W, Gong Y, Zhao J, Wang Y, Li B, Yang Y. A combined analysis of TyG index, SII index, and SIRI index: positive association with CHD risk and coronary atherosclerosis severity in patients with NAFLD. Front Endocrinol (Lausanne). 2023;14:1281839.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2765_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02721-9","volume":"24","author":"P Qin","year":"2025","unstructured":"Qin P, Ho FK, Celis-Morales CA, Pell JP. Association between systemic inflammation biomarkers and incident cardiovascular disease in 423,701 individuals: evidence from the UK biobank cohort. Cardiovasc Diabetol. 2025;24(1):162.","journal-title":"Cardiovasc Diabetol"},{"issue":"10354","key":"2765_CR12","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/S0140-6736(22)01483-0","volume":"400","author":"FA Wenzl","year":"2022","unstructured":"Wenzl FA, Kraler S, Ambler G, et al. Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation. Lancet. 2022;400(10354):744\u201356.","journal-title":"Lancet"},{"issue":"1","key":"2765_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","volume":"182","author":"B Shen","year":"2020","unstructured":"Shen B, Yi X, Sun Y, et al. Proteomic and metabolomic characterization of COVID-19 patient Sera. Cell. 2020;182(1):59\u2013e7215.","journal-title":"Cell"},{"key":"2765_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102409","volume":"68","author":"J Hu","year":"2024","unstructured":"Hu J, Xu J, Li M, et al. Identification and validation of an explainable prediction model of acute kidney injury with prognostic implications in critically ill children: a prospective multicenter cohort study. EClinicalMedicine. 2024;68:102409.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2765_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-022-01761-4","volume":"22","author":"S Yu","year":"2023","unstructured":"Yu S, Yan L, Yan J, et al. The predictive value of nontraditional lipid parameters for intracranial and extracranial atherosclerotic stenosis: a hospital-based observational study in China. Lipids Health Dis. 2023;22(1):16.","journal-title":"Lipids Health Dis"},{"key":"2765_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.925690","volume":"13","author":"R Xie","year":"2022","unstructured":"Xie R, Xiao M, Li L, et al. Association between SII and hepatic steatosis and liver fibrosis: a population-based study. Front Immunol. 2022;13:925690.","journal-title":"Front Immunol"},{"issue":"1","key":"2765_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2530792","volume":"57","author":"J Tang","year":"2025","unstructured":"Tang J, Li TX, Deng L, Huang XC, He PY, Zhao H. Inflammatory indices AISI and SIRI in atherosclerosis risk stratification: validation across community and intensive care populations. Ann Med. 2025;57(1):2530792.","journal-title":"Ann Med"},{"key":"2765_CR18","doi-asserted-by":"publisher","DOI":"10.2196\/66733","volume":"27","author":"J Lei","year":"2025","unstructured":"Lei J, Zhai J, Zhang Y, Qi J, Sun C. Supervised machine learning models for predicting sepsis-associated liver injury in patients with sepsis: development and validation study based on a multicenter cohort study. J Med Internet Res. 2025;27:e66733.","journal-title":"J Med Internet Res"},{"issue":"1","key":"2765_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jacl.2016.10.004","volume":"11","author":"M Paquette","year":"2017","unstructured":"Paquette M, Dufour R, Baass A. The Montreal-FH-SCORE: a new score to predict cardiovascular events in familial hypercholesterolemia. J Clin Lipidol. 2017;11(1):80\u20136.","journal-title":"J Clin Lipidol"},{"issue":"22","key":"2765_CR20","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1161\/CIRCULATIONAHA.116.024541","volume":"135","author":"L P\u00e9rez de Isla","year":"2017","unstructured":"P\u00e9rez de Isla L, Alonso R, Mata N, et al. Predicting cardiovascular events in Familial hypercholesterolemia: the SAFEHEART registry (Spanish Familial hypercholesterolemia cohort Study). Circulation. 2017;135(22):2133\u201344.","journal-title":"Circulation"},{"issue":"1","key":"2765_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/tjem.tjem_198_23","volume":"24","author":"MM Islam","year":"2024","unstructured":"Islam MM, Satici MO, Eroglu SE. Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: an extensive literature review. Turk J Emerg Med. 2024;24(1):8\u201319.","journal-title":"Turk J Emerg Med"},{"issue":"1","key":"2765_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01446-3","volume":"28","author":"YW Huang","year":"2023","unstructured":"Huang YW, Zhang Y, Feng C, An YH, Li ZP, Yin XS. Systemic inflammation response index as a clinical outcome evaluating tool and prognostic indicator for hospitalized stroke patients: a systematic review and meta-analysis. Eur J Med Res. 2023;28(1):474.","journal-title":"Eur J Med Res"},{"issue":"1","key":"2765_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-21131-2","volume":"25","author":"Y Cao","year":"2025","unstructured":"Cao Y, Wang W, Xie S, Xu Y, Lin Z. Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study. BMC Public Health. 2025;25(1):10.","journal-title":"BMC Public Health"},{"key":"2765_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1324890","volume":"15","author":"M Ma","year":"2024","unstructured":"Ma M, Wu K, Sun T, et al. Impacts of systemic inflammation response index on the prognosis of patients with ischemic heart failure after percutaneous coronary intervention. Front Immunol. 2024;15:1324890.","journal-title":"Front Immunol"},{"key":"2765_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1338025","volume":"15","author":"L Gu","year":"2024","unstructured":"Gu L, Xia Z, Qing B, et al. Systemic inflammatory response index (SIRI) is associated with all-cause mortality and cardiovascular mortality in population with chronic kidney disease: evidence from NHANES (2001\u20132018). Front Immunol. 2024;15:1338025.","journal-title":"Front Immunol"},{"key":"2765_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1439913","volume":"11","author":"TY Zhang","year":"2024","unstructured":"Zhang TY, Chen HL, Shi Y, Jin Y, Zhang Y, Chen Y. The relationship between system inflammation response index and coronary heart disease: a cross-sectional study (NHANES 2007\u20132016). Front Cardiovasc Med. 2024;11:1439913.","journal-title":"Front Cardiovasc Med"},{"key":"2765_CR27","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.2147\/JIR.S378309","volume":"15","author":"J Li","year":"2022","unstructured":"Li J, He D, Yu J, et al. Dynamic status of SII and SIRI alters the risk of cardiovascular diseases: evidence from Kailuan cohort study. J Inflamm Res. 2022;15:5945\u201357.","journal-title":"J Inflamm Res"},{"key":"2765_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/JIR.S283835","volume":"14","author":"Z Jin","year":"2021","unstructured":"Jin Z, Wu Q, Chen S, et al. The associations of two novel inflammation Indexes, SII and SIRI with the risks for cardiovascular diseases and All-Cause mortality: A Ten-Year Follow-Up study in 85,154 individuals. J Inflamm Res. 2021;14:131\u201340.","journal-title":"J Inflamm Res"},{"issue":"12","key":"2765_CR29","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"issue":"26","key":"2765_CR30","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497\u2013505.","journal-title":"N Engl J Med"},{"issue":"19","key":"2765_CR31","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383(19):1838\u201347.","journal-title":"N Engl J Med"},{"issue":"5","key":"2765_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2024.07.001","volume":"18","author":"F Mach","year":"2024","unstructured":"Mach F, Visseren FLJ, Cater NB, et al. Addressing residual risk beyond statin therapy: new targets in the management of dyslipidaemias-A report from the European society of cardiology cardiovascular round table. J Clin Lipidol. 2024;18(5):e685\u2013700.","journal-title":"J Clin Lipidol"},{"issue":"5","key":"2765_CR33","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1161\/STROKEAHA.113.004229","volume":"45","author":"G Sirimarco","year":"2014","unstructured":"Sirimarco G, Labreuche J, Bruckert E, et al. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. Stroke. 2014;45(5):1429\u201336.","journal-title":"Stroke"},{"issue":"1","key":"2765_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39911-y","volume":"13","author":"HG Lee","year":"2023","unstructured":"Lee HG, Park SD, Bae JW, et al. Machine learning approaches that use clinical, laboratory, and electrocardiogram data enhance the prediction of obstructive coronary artery disease. Sci Rep. 2023;13(1):12635.","journal-title":"Sci Rep"},{"issue":"1","key":"2765_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02538-y","volume":"23","author":"Y Chen","year":"2024","unstructured":"Chen Y, Yang Z, Liu Y, et al. Exploring the prognostic impact of triglyceride-glucose index in critically ill patients with first-ever stroke: insights from traditional methods and machine learning-based mortality prediction. Cardiovasc Diabetol. 2024;23(1):443.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"2765_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1001\/jama.2020.9517","volume":"324","author":"K Kinderknecht","year":"2020","unstructured":"Kinderknecht K, Harris C, Jones-Smith J. Association of the Healthy, Hunger-Free kids act with dietary quality among children in the US National school lunch program. JAMA. 2020;324(4):359\u201368.","journal-title":"JAMA"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02765-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02765-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02765-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:01:41Z","timestamp":1761811301000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02765-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2765"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02765-6","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NHANES has been approved by the National Center for Health Statistics Ethics Review Board. And the Ethical approval was obtained from the Ethics Committees of Guizhou Provincial People\u2019s Hospital (no. [2020]20)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors gave their consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"350"}}